- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Pfizer to send 7 lakh units of COVID drug Paxlovid to Taiwan
Health Minister Chen Shih-chung said the pills ordered would be enough to cover 3 percent of Taiwan's population, with half of them due to arrive in the second quarter this year.
Taipei - Taiwan has ordered 700,000 units of Pfizer Inc's anti-viral COVID-19 pill Paxlovid, its health minister said on Monday, amid a steady increase in the number of infections as the government pledges to gradually reopen its borders.
Taiwan has kept the pandemic well under control thanks to strict and early control measures. But daily infections have been rising in recent weeks, with 439 new cases reported on Monday, the second highest daily increase this year.
The government is on alert even though the numbers remain comparatively low and health ministry data shows 99.6% of those infected so far this year showed mild or no symptoms.
Health Minister Chen Shih-chung said the pills ordered would be enough to cover 3% of Taiwan's population, with half of them due to arrive in the second quarter this year.
"The medication could prevent serious illness and is very helpful for overall pandemic prevention," Chen told reporters.
Since the beginning of this year, Taiwan has reported 3,976 domestic cases, with only 13 people classified as being seriously ill and just two deaths.
Taiwan has maintained mandatory mask wearing and almost 80% of the population have had two vaccine shots while more than 50% have had three.
It is gradually relaxing quarantine rules for all arrivals on the island, but most foreigners apart from residents are still barred from entry.
Read also: Pfizer offers Voluntary Retirement Scheme for field staff
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story